Danish start-up Fuse Vectors has received $5.2 million in preseed financing to further develop their gene therapy technology.

Bio-Rad Laboratories, Inc has introduced Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 ...

These little vessels help in the grand scientific effort to understand the mechanisms of disease and to mitigate illness. One such virus, the adeno-associated virus (AAV), is the secret to gene ...

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications ...

However, scaling up AAV manufacturing to obtain sufficient yields to meet the demands of new research initiatives and clinical applications is challenging using traditional approaches. Download this ...

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications ...

In addition to AGTC, Solid Biosciences has adopted an HSV production system for its AAV production. Good help appears to be on the way. For more information, visit Vigene Biosciences.

The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its breakthrough approach, Fuse Vectors aims to be the universal solution for AAV ...

NewBiologix, a technology innovation company pioneering efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, today released a scientific white paper outlining ...

They infected Sf9 cell lines — derived from the fall armyworm — with three different baculoviruses: two containing essential genes for AAV particle production (rep and cap), and one containing ...

The United States Air Force (USAF) successfully tested the Barracuda-500, an autonomous aerial vehicle (AAV) developed by ...